Hims & Hers Launches $49 Wegovy Copycat Pill, Igniting Legal War With Novo Nordisk and Rattling the $150 Billion Weight-Loss Market
Hims & Hers Health launched a compounded semaglutide pill for $49 per month, undercutting Novo Nordisk's $149 Wegovy tablet by 67% and triggering legal threats that sent pharma stocks tumbling.